Standout Papers

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocar... 2022 2026 2023 2024131
  1. Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas (2022)
    Matthew H. G. Katz, Qian Shi et al. JAMA Oncology

Immediate Impact

9 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

Colorectal cancer
2024 Standout
Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2023 Standout
10 intermediate papers

Works of Robert Marsh being referenced

Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas
2022 Standout
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
2017
and 7 more

Author Peers

Author Last Decade Papers Cites
Robert Marsh 1715 869 861 75 2.2k
Enrico Aitini 1940 592 1021 82 2.7k
Jill N. Allen 1719 984 912 108 2.3k
Kenjiro Kotake 1902 971 752 114 2.5k
S. Jelić 1350 972 817 70 2.7k
Yogesh K. Vashist 1423 1224 943 109 2.4k
Ronald R. Salem 1456 1166 791 103 2.6k
Fabio Gelsomino 2240 483 500 71 2.6k
Pamela J. Hodul 1956 791 795 91 2.2k
Jesse S. Voss 842 774 689 70 2.0k
Knut Jørgen Labori 1179 683 492 101 1.5k

All Works

Loading papers...

Rankless by CCL
2026